论文信息 - TOP2A aberrations as predictive and prognostic marker in high-risk breast cancer patients. A randomized DBCG Trial (DBCG89D). - 字舞流文

TOP2A aberrations as predictive and prognostic marker in high-risk breast cancer patients. A randomized DBCG Trial (DBCG89D).

E. Balslev | K. Nielsen | B. Rasmussen | H. Mouridsen | J. Overgaard | B. Ejlertsen | J. T. Jørgensen | H. Knudsen | M. During | A. Knoop